Search | Syneos Health Communications

#1

Responding to rampant criticism of rising drug prices, pharma giant Eli Lilly will begin selling an authorized generic of its preeminent insulin therapy, Humalog, at half-price.

#2

The producers of As Much As I Can, which just finished its run at NoHo’s Joe’s Pub, are the folks at ViiV Healthcare, a group venture formed by Pfizer, GSK and Shionogi, and they hope their play will help ameliorate the plight of people with HIV.

#3

Nestlé, the brand you might associate first with such decadent confections as Crunch bars, Laffy Taffy, and Toll House cookies, has made a decided turn toward the healthful.

#4

Forecasting next year’s biggest shifts within the healthcare landscape, Syneos Health has released 2019 Health Trend Ten, available for download now, which explicates ten of the trends that will redefine healthcare globally.

#5

Though once overwhelmed by the pandemic, many healthcare systems have already restructured themselves after learning critical lessons from COVID-19.

#6

GlaxoSmithKline announced that it will acquire Waltham, Massachusetts-based drug company Tesaro, which develops novel cancer treatments, for $5.1 billion cash.

#7

The growing appeal of orphan drugs to manufacturers isn’t a groundbreaking story, but a new report identifies some head-spinning facts behind the focal shift from blockbuster to rare-disease drugs.

#8

23andMe, the spit-kit DNA test company that announced a partnership with GSK last year, is embarking on a new health care foray.

#9

Pfizer and Novartis have been independently developing therapies for nonalcoholic steatohepatitis (NASH), and they’re now set to join forces to yield a combination therapy for the fatty liver disease linked closely with metabolic disorders.

#10

The COVID-19 guidelines released by the Centers for Disease Control (CDC) in May, proclaiming that vaccinated people no longer needed to wear masks indoors, spurred widespread joy, seeming to herald the beginning of the end of times unprecedented.

#11

With about 700 million COVID-19 vaccine doses administered across the globe, the return to (relative) normalcy, in many parts of the world, is starting to feel closer and closer.

#12

Advantia Health, a leading-edge medical company committed to empowering women with integrated health care services, announced a new partnership with Elligo Health Research, which will offer Advantia’s clients access to a whole new realm of resources, through clinical trials.

#13

Given the totally upending effects of the COVID-19 crisis, it may be easy to forget that it started during another public health crisis, the opioid epidemic—but now we’re starting to see the devastating impact of the confluence of the two.

#14

Deploying ambassadors to speak at the marketing conference DigiPharma Connect, Snapchat is vying to position itself as the best social media outlet for pharma marketing.

#15

Complications from drug interactions can present patients with whole new afflictions.

#16

Pharmaceutical giant Roche’s new app for people with multiple sclerosis (MS) revolutionizes how doctors care for patients with the disease.

#17

Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.

#18

In some rooms at Cedars-Sinai Hospital, patients won’t spend a moment alone—sort of—now that the leading Beverly Hills medical center has partnered with Aiva Health to make select rooms smart.

#19

The FDA approved Biohaven Pharmaceuticals’ migraine therapy, Nurtec, last month, just before the COVID-19 pandemic sent people the world over into lockdown.

#20

After taking some major leaps into healthcare, Google has begun solidifying its foothold in the space by appointing Dr.

#21

Health care was a central part of the discussion at this year’s Facebook F8.

#22

With earbuds dangling, leaders dialed in from all over the globe to share their expertise with one another and listeners on Zoom.

#23

Based on data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, one of the largest-ever clinical trials for depression, a startup called Taliaz is helping physicians pick the right antidepressant therapy off the bat.

#24

For decades, an Alzheimers cure has eluded scientists, who can only recognize the disease once it’s too late.

#25

Cannes Lions 2021: The Behavioral Science Behind Choice Winners

#26

A New York Times op-ed highlights the problems in American healthcare that are making doctors depressed.

#27

Ten years after acquiring its competitor Duane Reade, Walgreens has set its sights on a whole different type of growth, announcing its plan to establish doctor’s offices in hundreds of its familiar brick-and-mortar stores.

#28

As the use of artificial intelligence in R&D continues to rise, Novartis takes it even further, equipping its reps with AI that suggests the perfect things to talk about with HCPs.

#29

Holistic healthcare brand Otsuka Pharmaceutical has announced a promising partnership with Science 37, the trailblazing startup out of MIT that’s transforming clinical trials for everyone.

#30

Facebook is launching Preventive Health, a program designed to make its feed-scrollers the world over more health-conscious, especially when it comes to cancer, heart disease, and the flu.

Search Results

Connect

Site

Search Results

Connect

Site

Subscribe to our RSS feed